BIOMEDICA CROBIOMEDICA CRO
  • +38 (068) 150 70 04
  • office@biomedica-cro.com
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • ENEN
    • UAUA
Search
SEND REQUEST
  • Biospecimens
    • Tissue Samples
    • Blood samples
    • Other Biofluids
    • Inventory
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts
  • Home
  • Blog
  • Assessing stool specimens form and artificial intelligence • BIOMEDICA CRO

Assessing stool specimens form and artificial intelligence • BIOMEDICA CRO

Assessing stool specimens form and artificial intelligence • BIOMEDICA CRO

24.05.2022
Stool specimens characterization via novel smartphone application - the review of the latest innovations by BIOMEDICA CRO
admin2024-05-29T14:43:41+00:00

Stool specimens characterization via novel smartphone application – a review of the latest innovations in Gastroenterology by BIOMEDICA CRO.

An innovative mobile phone application was found to be as good as expert gastroenterologists at characterizing stool, according to a study by Cedars-Sinai.
Stool reporting by patients, usually guided by the Bristol Stool Scale, is crucial to helping physicians evaluate symptoms for diagnosis or for judging the effectiveness of medications. The artificial intelligence (AI) used in the smartphone app also outperformed reports by patients describing their stool specimens.

“The artificial intelligence tool removes the subjective description that can be part of a patient’s description of their bowel specimens. In addition to improving a physician’s ability to assess their patients’ digestive health, this app could be advantageous for clinical trials by reducing the variability of stool outcome measures,” said Ali Rezaie, MD, co-author of the study and the medical director of GI Motility at Cedars-Sinai.

Please find more information at the American Journal of Gastroenterology, articles, “A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form”.

BIOMEDICA CRO team is proud to participate in preclinical trials, drug discovery, development of new laboratory devices, technologies and other scientific projects.
We collect various human biospecimens, including stool, from diseased and normal donors since 2017. There is a good network of contracted clinical sites in different disease areas and we are ready to make new connections if necessary.

BIOMEDICA CRO is open for the new requests with sample processing protocols that will work the best way for your investigations.
Despite Russian aggression, our team continues to work as usual. We would be happy to answer all of your questions and provide you with more information.

Please email us at  office@biomedica-cro.com / LinkedIn  to receive high-quality human biospecimens and associated data for your studies.

Share this post

Facebook Twitter LinkedIn
All publications
Esophageal and Gastric cancers investigations and BIOMEDICA CRO contribution
BIOMEDICA CRO can support Traumatic Brain Injury (TBI) researches
  • Biospecimens
  • Disease Areas
  • Ethics
  • Blog
  • About us
  • Contacts

Privacy Policy | Terms of use

Linkedin

Site development mamontova design

BIOMEDICA CRO
© 2021 | All rights reserved

View the Inventory

Click on the button "Download the inventory" to review the list of ready-to-ship biospecimens.

Download the Inventory

Iryna Iurkova

Business Development Director

Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.

Serhii Samsoniuk

Chief Executive Officer

Mr. Samsoniuk is a pharmaceutical expert with over 15 years of industry experience. Over the course of his career, he has held key leadership roles at both international and local companies, such as GlaxoSmithKline, B.Braun, and Sona Exim, overseeing strategic marketing, sales, and key account management. Before joining BIOMEDICA CRO team, he led business development efforts in the CCA+ region at Farmak, driven by a commitment to professional ethics and strategic partnership.

Anton Zubov - MD, BIOMEDICA CRO Co-Founder, Board Member

Anton Zubov

MD, BIOMEDICA CRO Co-Founder,
Board Member

Dr. Zubov has over 21 years of experience in the international pharmaceutical markets. He has held numerous leading positions in marketing, management and sales at Schering AG and Bayer Pharmaceuticals. He has made a career internationally with positions in Ukraine, Germany and Central Asia. In 2017, together with Dr. Kupnovitsky, he founded BIOMEDICA CRO and during the first years was its CINO. Dr. Zubov is currently a Marketing & Sales Director of the CIS Region in Farmak and Board Member of BIOMEDICA CRO Supervisory Board.

have any questions?

Send request

Fill out the form and we will contact you shortly

    Name

    E-mail

    Your message


    have any questions?

    Send request

    Please send us a message and we’ll be back to you shortly

      Name

      Company name

      E-mail

      Your message

      Ostap Kupnovitsky - PhD, MD, MBA, BIOMEDICA CRO Co-Founder, Chairman of the Supervisory Board

      Ostap Kupnovitsky

      PhD, MD, MBA,
      BIOMEDICA CRO Co-Founder,
      Chairman of the Supervisory Board

      Dr. Kupnovitsky has a vast experience in the pharmaceutical market. He was the Regional Director of Organon and Serono in Ukraine. In 2003, he became a Co-Founder and Director of Sona-Pharm, the firm that started its activity in Ukraine and has flourished into an international marketing company with its representatives throughout the CIS region. Since 2017, when BIOMEDICA CRO was founded, he has been a distinguished Chairman of its Supervisory Board.